Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Radium Life Tech CoTPE:2547 +2.90%64 EBITDA Margin % is 40.77% as of Mar. 2026, which is 30% above its 10-year median of 31.31. GuruFocus rates TPE:2547 with a GF Score™ of 64/100 and a GF Value™ of NT$8.37 (Modestly Overvalued). The stock has 11 warning signs investors should review. Among 542 Conglomerates companies, Radium Life Tech Co ranks better than 89.3% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Radium Life Tech Co's EBITDA for the
three
months ended in Mar. 2026 was NT$654 Mil. Radium Life Tech Co's Revenue for the
three
months ended in Mar. 2026 was NT$1,604 Mil. Therefore, Radium Life Tech Co's EBITDA margin for the quarter that ended in Mar. 2026 was 40.77%.
Radium Life Tech Co (TPE:2547) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Radium Life Tech Co EBITDA Margin % Related Terms
Radium Life Tech Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Radium Life Tech Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Radium Life Tech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Radium Life Tech Co EBITDA Margin % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Radium Life Tech Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Radium Life Tech Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Radium Life Tech Co (TPE:2547) has a EBITDA Margin % of 40.77% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Radium Life Tech Co and its competitors. This is 30% above median its historical median of 31.31. According to the industry distribution chart, Radium Life Tech Co ranks #58 out of 542 companies in the Conglomerates industry, placing it in the top 10.7%.
Is Radium Life Tech Co's EBITDA Margin % too high?
Radium Life Tech Co's current EBITDA Margin % of 40.77% is 30% above median its 10-year median of 31.31. The Conglomerates industry median EBITDA Margin % is 12.31. Radium Life Tech Co's value of 40.77% is 231.3% above this industry median. Based on the distribution chart, Radium Life Tech Co ranks #58 out of 542 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, Radium Life Tech Co has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Radium Life Tech Co's EBITDA Margin % compare to MMM and HON?
According to the Conglomerates industry distribution chart, Radium Life Tech Co ranks #58 out of 542 companies for EBITDA Margin %. This places Radium Life Tech Co in the top 11% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 12.31. Radium Life Tech Co's value of 40.77% is 231.3% above this benchmark. While the company's 10-year median is 31.31 vs. the industry median of 12.31, Radium Life Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Conglomerates company?
The median EBITDA Margin % among Conglomerates companies is 12.31, based on 542 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Radium Life Tech Co's current EBITDA Margin % of 40.77% is 231.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Radium Life Tech Co and its competitors. For the Conglomerates industry, the median EBITDA Margin % is 12.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Radium Life Tech Co's current EBITDA Margin % is 40.77%, which is 30% above median its own 10-year median of 31.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radium Life Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Radium Life Tech Co (TPE:2547) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$8.37, compared to a current price of NT$10.65 — trading 27.2% above its estimated fair value. The current EBITDA Margin % is 40.77%, which is 30% above median its 10-year median of 31.31 and 231.3% above the Conglomerates industry median of 12.31. Radium Life Tech Co's overall GF Score™ is 64/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Radium Life Tech Co (TPE:2547), the current EBITDA Margin % is 40.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Radium Life Tech Co (TPE:2547) Overvalued in 2026?
Based on GuruFocus' analysis, Radium Life Tech Co stock appears to be overvalued.
The current stock price of NT$10.65 is trading 27.2% above its estimated GF Value™ of NT$8.37.
GuruFocus considers Radium Life Tech Co to be Modestly Overvalued.
Key valuation signals for TPE:2547:
EBITDA Margin %: 40.77% (30% above median its 10-year median of 31.31)
GF Value™: NT$8.37 vs. price of NT$10.65 (27.2% above fair value)
Industry Position: 231.3% above the Conglomerates median (#58 of 542)
No single metric tells the full story. See the TPE:2547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Radium Life Tech Co Ltd is engaged in the development, sale, and leasing of residential and commercial buildings constructed by independent construction contractors. The company's business includes commissioning construction companies to build public housing projects and commercial buildings for rental and sale and managing the industrial competent authorities of the government to engage in the development, lease, sale, and management of industrial zones.
64GF Score
Get the complete analysis for TPE:2547
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:2547 has been successfully added to your 
